Registered medicine · price not in DRAP list
FUNGE 125 mg
Terbinafine Hydrochloride · 125 mg · Tablet
₨ Price status
Not in DRAP list
10s
No official DRAP price published for this brand · Market price: not yet recorded
DRAP registration
Medicine details
FUNGE contains Terbinafine Hydrochloride and is registered with DRAP under number 040949, marketed by WILSHIRE LABORATORIES (PVT) LTD.. Its price is not in DRAP's published price list.
| Brand | FUNGE |
|---|---|
| Medicine (generic) | Terbinafine Hydrochloride |
| Composition (DRAP registry) | Terbinafine Hydrochloride equivalent to Terbinafine ...... 125 mg |
| Strength | 125 mg |
| Dosage form | Tablet |
| Pack sizes | 10s |
| Company | WILSHIRE LABORATORIES (PVT) LTD. |
| DRAP registration no. | 040949 |
| Registered since | 2005-07-03 |
Price comparison
Same medicine with official DRAP prices
Same generic · same dosage form first · lowest pack price first
| Brand | Company | Form and pack | Official DRAP price |
|---|---|---|---|
| Fibi 125 mg | Winlet Pharmaceuticals (Pvt) Ltd. | Tablet, 10's | PKR 439.07 |
| Anibret 125 mg | Epharm Laboratories | Tablet, 10's | PKR 447.60 |
| Terbizor 125 mg | Bryon Pharmaceuticals (Pvt.) Ltd | Tablet, 1x10's | PKR 464.43 |
| Tacoma 125 mg | De-Mont Research Laboratories (Pvt.) Ltd. | Tablet, 10's | PKR 518.49 |
| Sebifin 125 mg | Seraph Pharmaceutical | Tablet, 1x10's | PKR 561.43 |
| Lami-Med 125 mg | Mediate Pharmaceutical Pvt Ltd | Tablet, 10’s | PKR 569.27 |
| Terbimed 125 mg | Medera Pharmaceuticals (Pvt) Ltd | Tablet, 10's | PKR 607.68 |
| TERBISER 125 mg | Panacea Pharmaceuticals | Tablet, 10 | PKR 646.44 |
| Fibi 250 mg | Winlet Pharmaceuticals (Pvt) Ltd. | Tablet, 10's | PKR 701.39 |
| Anibret 250 mg | Epharm Laboratories | Tablet, 10's | PKR 715.02 |
Sources: DRAP registered-product records and published lists. Always follow your doctor's or pharmacist's advice before switching brands.
Market price
Price seen in the market
Printed MRP · latest per pack · reviewed by MedInfoBase
No market price recorded yet. Prices of deregulated medicines are set by companies and can change; help by reporting the price printed on the pack.
